Innovative Medicine Basic Research and Development /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Tokyo :
Springer Japan : Imprint: Springer,
2015.
|
| Edición: | 1st ed. 2015. |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-4-431-55651-0 |
Tabla de Contenidos:
- Part I Basic Research for Innovative Medicine
- 1. Diverting Glycolysis to Combat Oxidative Stress
- 2. Metabolic Regulation by Nuclear Receptors
- 3. Fighting Fire with Fire in Cancer
- 4. Linear Polyubiquitination: a Crucial Regulator of NF-kB Activation
- 5. VCP, a major ATPase in the cells, as a novel drug target for currently incurable disorders
- 6. Roles of E-cadherin in hepatocarcinogenesis
- 7. The Hippo Signaling Pathway: A Candidate New Drug Target for Malignant Tumors
- 8. Inhibitory immunoreceptors on mast cells in allergy and inflammation
- 9. Doxycycline-inducible Autoimmune Blistering Skin Disease Model
- 10. T-cell Senescence and Autoimmunity
- Part II Translational Research for Innovative Medicine
- 11. IL-6: A new era for the treatment of autoimmune inflammatory diseases
- 12. Pathogenesis of Non-alcoholic Steatohepatitis and Its Potential Therapeutic Strategies
- 13. Multifaceted translational approach of major mental illness
- 14. Translational research of leptin in lipodystrophy and its related diseases
- 15. Translational research of the activation of the C-type natriuretic peptide (CNP)-guanylyl cyclase-B pathway for skeletal dysplasia
- 16. Clarity and Challenges in Tissue Fibrosis
- 17. TRP Channels: Their Function and Potentiality as Drug Targets
- 18. Autophagic Cell Death and Cancer Chemotherapeutics
- 19. Adrenomedullin as a Potential Therapeutic Agent for Refractory Ulcerative Colitis
- 20. RNA activation
- Part III New Technology for Innovative Medicine
- 21. Cardiac Reprogramming for Heart Repair
- 22. Development of a new in vivo optical probe for biological diagnosis and therapy
- 23. Introduction of mesenchymal stem cells for liver surgery (hepatectomy and transplantation)
- 24. Synaptic and axonal plasticity induction in the human cerebral cortex
- 25. TIM-3 is a novel therapeutic target for eradicating acute myelogenous leukemia stem cells
- 26. TGF-beta LAP degradation products, a novel biomarker and promising therapeutic target for liver fibrogenesis
- 27. Cell-based regenerative therapy for liver disease.